Dar Al-Shifa Pharmaceuticals Company

PHARMACARE

PS2014112861

Pharmaceuticals

End-of-day quote Palestine Exchange Other stock markets 06:00:00 2022-12-18 pm EST			5-day change	1st Jan Change
3.35 ^USD	+4.69%		-.--%	-.--%

2022	Dar Al-Shifa Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2021	CI
2021	Dar Al-Shifa Pharmaceuticals Company Reports Earnings Results for the Nine Months Ended September 30, 2021	CI

Dar Al-Shifa Pharmaceuticals. Co. Announces Unconsolidated Financial Results for the First Quarter Ended April 30, 2014

June 31, 2014

Dar Al-Shifa Pharmaceuticals. Co. announced unconsolidated financial results for the first quarter ended April 30, 2014.

For the period, the company reported net profit after taxes of USD 746,063.

Latest news about Dar Al-Shifa Pharmaceuticals Company

Dar Al-Shifa Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-09-11	CI
Dar Al-Shifa Pharmaceuticals Company Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-29	CI
Dar Al-Shifa Pharmaceuticals Company Reports Unaudited Preliminary Earnings Results for the Full Year Ended December 31, 2014	15-02-18	CI
Dar Al-Shifa Pharmaceuticals. Co. Announces Unconsolidated Financial Results for the First Quarter Ended April 30, 2014	14-05-31	CI
Dar Al-Shifa Pharmaceuticals. Co. Announces Unaudited Preliminary Financial Results for Year Ended December 31, 2013	14-02-12	CI

Chart Dar Al-Shifa Pharmaceuticals Company

Duration

Period

Chart Dar Al-Shifa Pharmaceuticals Company

More charts

Pharmacare PLC is a Palestine-based company engaged in the pharmaceutical sector. The Company manufactures and distributes medical products, such as antibiotics, general and veterinary drugs. The Company owns and operates two distribution centers in Betunia and Gaza city; A drugstore based in Jerusalem, and licensed by the Ministry of Health; a science center in Gaza city; a marketing center in Betunia, which supports the activities of the Company and others, and representative offices in Russia, Belarus, Yemen and Romania. The Companyâs products are exported to a range of regional and international markets. The Company's products include Klaricare, Ciprocare, Megacare Forte, Amoxicare and Fluoxicare, among others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DAR AL-SHIFA PHARMACEUTICALS COMPANY	-.--%	30.15M
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B